In its original complaint, Louisiana argued the Biden administration expanded access to mifepristone without properly considering potential safety risks. The state also argued the policy violated the Comstock Act, which generally prohibits sending abortion drugs by mail.
The court continued the freeze on restrictions imposed by Louisiana on the drug, mifepristone. The post Supreme Court Allows Temporary Access to Abortion Drug By Mail appeared first on The American Conservative .
The Supreme Court ruled Thursday to continue its temporary stay on Louisiana’s restrictions on mifepristone, a popular abortion drug. This freeze was requested by the plaintiff Danco Laboratories, LLC, the manufacturers of the drug, until the court delivers a concrete ruling. Mifepristone is one of two widely used abortion drugs which Louisiana last fall mandated be dispensed in person. According to Axios , telehealth prescriptions and deliveries make up more than 60 percent of abortions in the U.S. healthcare system. Offering his dissent , Associate Justice Clarence Thomas rejected the argument for a continued freeze. “Applicants are not entitled to a stay of an adverse court order based on lost profits from their criminal…Open